Daiichi Sankyo Company Ltd
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Daiichi Sankyo Company Ltd is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Daiichi Sankyo Company Ltd in the same report. This provides an indication of potential competitors or associated to Daiichi Sankyo Company Ltd. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H2 2016

DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H2 2016


2016-11-30
Global Markets Direct’s, ‘DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H2 2016’, provides in depth analysis on DNA Gyrase Subunit B (EC 5.99.1.3) targeted pipeline therapeutics.

The report provides comprehensive information on...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0701TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0701TDB
  • View Report: Research and Experts Market Report: Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H2 2016

    Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fibrodysplasia Ossificans Progressiva – Pipeline Review, H2 2016, provides an overview of the Fibrodysplasia Ossificans Progressiva (Musculoskeletal Disorders)...
  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8910IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8910IDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2016

    Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2016, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease (Nutritional...
  • Market Report
  • Nutritional Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8857IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8857IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Pertussis (Whooping Cough) - Pipeline Review, H2 2016

    Pertussis (Whooping Cough) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pertussis (Whooping Cough) – Pipeline Review, H2 2016, provides an overview of the Pertussis (Whooping Cough) (Infectious Disease) pipeline landscape.

    Pertussis,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8850IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8850IDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anemia in Chronic Kidney Disease – Pipeline Review, H2 2016, provides an overview of the Anemia in Chronic Kidney Disease (Hematological Disorders) pipeline...
  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8849IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8849IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H2 2016

    Colon Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides an overview of the Colon Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts in the large...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8848IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8848IDB
  • View Report: Research and Experts Market Report: Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3...

    Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0691TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0691TDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H2 2016

    Neuropathic Pain - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain – Pipeline Review, H2 2016, provides an overview of the Neuropathic Pain (Central Nervous System) pipeline landscape.

    Neuropathic pain, or...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8861IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8861IDB
  • View Report: Research and Experts Market Report: Bacterial Pneumonia - Pipeline Review, H2 2016

    Bacterial Pneumonia - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bacterial Pneumonia – Pipeline Review, H2 2016, provides an overview of the Bacterial Pneumonia (Infectious Disease) pipeline landscape.

    Bacterial pneumonia...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8851IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8851IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H2 2016

    Multiple Sclerosis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Sclerosis – Pipeline Review, H2 2016, provides an overview of the Multiple Sclerosis (Central Nervous System) pipeline landscape.

    Multiple sclerosis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8845IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8845IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H2 2016

    Hypertension - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

    Hypertension, also referred to as high...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8829IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8829IDB
  • View Report: Research and Experts Market Report: Poliomyelitis - Pipeline Review, H2 2016

    Poliomyelitis - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Poliomyelitis – Pipeline Review, H2 2016, provides an overview of the Poliomyelitis (Infectious Disease) pipeline landscape.

    Polio is a highly infectious disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8824IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8824IDB
  • View Report: Research and Experts Market Report: Streptococcal Pneumonia - Pipeline Review, H2 2016

    Streptococcal Pneumonia - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Streptococcal Pneumonia – Pipeline Review, H2 2016, provides an overview of the Streptococcal Pneumonia (Infectious Disease) pipeline landscape.

    Pneumococcal...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8822IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8822IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H2, 2016

    Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3887CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3887CTIDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H2, 2016

    Venous Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3886CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3886CTIDB
  • View Report: Research and Experts Market Report: BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin...

    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0674TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0674TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or...

    Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta (Nuclear Factor NF Kappa B Inhibitor Kinase Beta or I Kappa B Kinase 2 or IKBKB or EC 2.7.11.10) - Pipeline Review, H2 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0660TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0660TDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H2 2016

    Age Related Macular Degeneration - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Pipeline Review, H2 2016, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape.

    Age...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8804IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8804IDB
  • View Report: Research and Experts Market Report: Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016

    Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H2 2016’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0654TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0654TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Market Report: Liposarcoma Global Clinical Trials Review, H2, 2016

    Liposarcoma Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Liposarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Liposarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Liposarcoma. Report...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3871CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3871CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Anaplastic Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Anaplastic Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3863CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3863CTIDB
  • View Report: Research and Experts Market Report: Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin...

    Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21.) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0629TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0629TDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Stroke - Pipeline Review, H2 2016

    Stroke - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

    Stroke is a condition in which the brain cells suddenly...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8726IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8726IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2016, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8721IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8721IDB
  • View Report: Research and Experts Market Report: Pigmented Villonodular Synovitis - Pipeline Review, H2 2016

    Pigmented Villonodular Synovitis - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis – Pipeline Review, H2 2016, provides an overview of the Pigmented Villonodular Synovitis (Musculoskeletal Disorders) pipeline...
  • Market Report
  • Musculoskeletal Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8714IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8714IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Market Report: Cancer Pain - Pipeline Review, H2 2016

    Cancer Pain - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cancer Pain – Pipeline Review, H2 2016, provides an overview of the Cancer Pain (Central Nervous System) pipeline landscape.

    Cancer pain can be defined as a...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8691IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8691IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H2 2016

    Malaria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

    Malaria is a life-threatening blood disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8670IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8670IDB
  • View Report: Research and Experts Market Report: Diphtheria - Pipeline Review, H2 2016

    Diphtheria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria – Pipeline Review, H2 2016, provides an overview of the Diphtheria (Infectious Disease) pipeline landscape.

    Diphtheria is a bacterial infection that...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8651IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8651IDB
  • View Report: Research and Experts Market Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2016

    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastrointestinal Stromal Tumor – Pipeline Review, H2 2016, provides an overview of the Gastrointestinal Stromal Tumor (Oncology) pipeline landscape.

    Gastrointestinal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8645IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8645IDB
  • View Report: Research and Experts Market Report: Rubella (German Measles) - Pipeline Review, H2 2016

    Rubella (German Measles) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rubella (German Measles) – Pipeline Review, H2 2016, provides an overview of the Rubella (German Measles) (Infectious Disease) pipeline landscape.

    Rubella also...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8643IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8643IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Kaposi Sarcoma Global Clinical Trials Review, H2, 2016

    Kaposi Sarcoma Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kaposi Sarcoma Global Clinical Trials Review, H2, 2016" provides an overview of Kaposi Sarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Kaposi Sarcoma....
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3795CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3795CTIDB
  • View Report: Research and Experts Market Report: Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016

    Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016" provides an overview of Bordetella pertussis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3790CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3790CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Atherosclerosis - Pipeline Review, H2 2016

    Atherosclerosis - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis – Pipeline Review, H2 2016, provides an overview of the Atherosclerosis (Cardiovascular) pipeline landscape.

    Atherosclerosis (or arteriosclerotic...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8629IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8629IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Restless Legs Syndrome Global Clinical Trials Review, H2, 2016

    Restless Legs Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Restless Legs Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Restless Legs Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3787CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3787CTIDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016

    Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Postherpetic Neuralgia Global Clinical Trials Review, H2, 2016" provides an overview of Postherpetic Neuralgia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3782CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3782CTIDB
  • View Report: Research and Experts Market Report: Fibromyalgia Global Clinical Trials Review, H2, 2016

    Fibromyalgia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Fibromyalgia Global Clinical Trials Review, H2, 2016" provides an overview of Fibromyalgia clinical trials scenario. This report provides top line data relating to the clinical trials on Fibromyalgia....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3781CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3781CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025


    2016-08-08
    Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery occlusi...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC131PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC131PIDR
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections - Pipeline Review, H2 2016

    Haemophilus influenzae Type B Infections - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Haemophilus influenzae Type B Infections – Pipeline Review, H2 2016, provides an overview of the Haemophilus influenzae Type B Infections (Infectious Disease)...
  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8617IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8617IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H2 2016

    Osteoporosis - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoporosis – Pipeline Review, H2 2016, provides an overview of the Osteoporosis (Metabolic Disorders) pipeline landscape.

    Osteoporosis, or thinning bones,...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8638IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2016

    Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Clostridium difficile Infections – Pipeline Review, H2 2016, provides an overview of the Clostridium difficile Infections (Infectious Disease) pipeline landscape.

    Cl...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8583IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8583IDB
  • View Report: Research and Experts Market Report: Measles - Pipeline Review, H2 2016

    Measles - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Measles – Pipeline Review, H2 2016, provides an overview of the Measles (Infectious Disease) pipeline landscape.

    Measles is a highly infectious viral disease....

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8572IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8572IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...
  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8528IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8528IDB
  • View Report: Research and Experts Market Report: Papillary Thyroid Cancer - Pipeline Review, H2 2016

    Papillary Thyroid Cancer - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Papillary Thyroid Cancer – Pipeline Review, H2 2016, provides an overview of the Papillary Thyroid Cancer (Oncology) pipeline landscape.

    Papillary thyroid cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8512IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8512IDB
  • View Report: Research and Experts Market Report: Pyelonephritis Global Clinical Trials Review, H2, 2016

    Pyelonephritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Pyelonephritis Global Clinical Trials Review, H2, 2016" provides an overview of Pyelonephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Pyelonephritis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3760CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3760CTIDB
  • View Report: Research and Experts Market Report: Ischemic Stroke Global Clinical Trials Review, H2, 2016

    Ischemic Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ischemic Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemic...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3757CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3757CTIDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016

    Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Acute Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3755CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3755CTIDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation Global Clinical Trials Review, H2, 2016

    Atrial Fibrillation Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Fibrillation clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3754CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3754CTIDB
  • View Report: Research and Experts Market Report: Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016

    Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3750CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3750CTIDB
  • View Report: Research and Experts Market Report: Diphtheria Global Clinical Trials Review, H2, 2016

    Diphtheria Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2016" provides an overview of Diphtheria clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3743CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3743CTIDB
  • View Report: Research and Experts Market Report: Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2...

    Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2016’, provides in depth analysis on Transmembrane Prolyl 4 Hydroxylase (Hypoxia...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0551TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0551TDB
  • View Report: Research and Experts Market Report: Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review,...

    Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016’, provides in depth analysis on Acyl CoA Desaturase (Fatty Acid Desaturase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0550TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0550TDB
  • View Report: Research and Experts Market Report: Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member...

    Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0547TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0547TDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke - Pipeline Review, H2 2016

    Acute Ischemic Stroke - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H2 2016’, provides an overview of the Acute Ischemic Stroke pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8495IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8495IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H2 2016

    Postherpetic Neuralgia - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8487IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8487IDB
  • View Report: Research and Experts Market Report: Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016

    Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Malignant Fibrous Histiocytoma Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Fibrous Histiocytoma clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3722CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3722CTIDB
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016

    Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1) - Pipeline Review, H2 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G Protein Coupled Receptor 40 or GPR40 or FFAR1)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0516TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0516TDB
  • View Report: Research and Experts Market Report: Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016

    Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H2 2016’, provides in depth analysis on Glucose Dependent Insulinotropic Receptor (G Protein Coupled Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0515TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0515TDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H2 2016

    Chronic Pain - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H2 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8545IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8545IDB
  • View Report: Research and Experts Market Report: Dystrophin (DMD) - Pipeline Review, H2 2016

    Dystrophin (DMD) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Dystrophin (DMD) - Pipeline Review, H2 2016’, provides in depth analysis on Dystrophin (DMD) targeted pipeline therapeutics.

    The report provides comprehensive information on the Dystrophin (DMD), targeted therapeutics,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0502TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0502TDB
  • View Report: Research and Experts Market Report: Chronic Asthma Global Clinical Trials Review, H2, 2016

    Chronic Asthma Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Chronic Asthma Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3676CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3676CTIDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Current and Future Players

    Fibromyalgia - Current and Future Players


    2015-05-01
    GlobalData has released its pharma report, “Fibromyalgia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Fibromyalgia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1058FPR has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC1058FPR
  • View Report: Research and Experts Market Report: Dyslipidemia - Current and Future Players

    Dyslipidemia - Current and Future Players


    2015-05-05
    GlobalData has released its pharma report, “Dyslipidemia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dyslipidemia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1056FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1056FPR
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8420IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8420IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H2 2016

    Dyslipidemia - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H2 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8412IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8412IDB
  • View Report: Research and Experts Market Report: Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor...

    Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Proto Oncogene Tyrosine Protein Kinase ROS (Proto Oncogene c Ros 1 or Receptor Tyrosine Kinase c Ros Oncogene 1 or c Ros Receptor Tyrosine Kinase or ROS1 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0487TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0487TDB
  • View Report: Research and Experts Market Report: Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43)...

    Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Histone Lysine N Methyltransferase EZH2 (ENX 1 or Enhancer Of Zeste Homolog 2 or Lysine N Methyltransferase 6 or EZH2 or EC 2.1.1.43) - Pipeline Review, H2 2016’, provides in depth analysis on Histone Lysine N...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0483TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0483TDB
  • View Report: Research and Experts Market Report: Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016

    Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) - Pipeline Review, H2 2016’, provides in depth analysis on Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) targeted pipeline therapeutics.

    The...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0477TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0477TDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H2 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8388IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8388IDB
  • View Report: Research and Experts Market Report: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8376IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8376IDB
  • View Report: Research and Experts Market Report: Fibrosarcoma - Pipeline Review, H2 2016

    Fibrosarcoma - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Fibrosarcoma - Pipeline Review, H2 2016’, provides an overview of the Fibrosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fibrosarcoma, complete...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8374IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8374IDB
  • View Report: Research and Experts Market Report: E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.)...

    E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2016’, provides in depth analysis on E3 Ubiquitin Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0462TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0462TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's Disease (Regional Enteritis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8354IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8354IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H2 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H2 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Genetic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8342IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8342IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H2 2016

    Atrial Fibrillation - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H2 2016’, provides an overview of the Atrial Fibrillation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atrial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8335IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8335IDB
  • View Report: Research and Experts Market Report: Stable Angina Global Clinical Trials Review, H2, 2016

    Stable Angina Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Stable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Stable Angina. Report includes...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3607CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3607CTIDB
  • View Report: Research and Experts Market Report: Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016

    Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Coronary Artery Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3602CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3602CTIDB
  • View Report: Research and Experts Market Report: Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016

    Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Chronic Thromboembolic Pulmonary Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Thromboembolic Pulmonary Hypertension clinical trials scenario. This report provides top line data...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3591CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3591CTIDB
  • View Report: Research and Experts Market Report: Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016

    Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Spastic Cerebral Palsy Global Clinical Trials Review, H2, 2016" provides an overview of Spastic Cerebral Palsy clinical trials scenario. This report provides top line data relating to the clinical trials on Spastic Cerebral...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3575CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3575CTIDB
  • View Report: Research and Experts Market Report: High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein...

    High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) - Pipeline


    2016-07-27
    ‘High Affinity Nerve Growth Factor Receptor (Neurotrophic Tyrosine Kinase Receptor Type 1 or TRK1 Transforming Tyrosine Kinase Protein or Tropomyosin Related Kinase A or Tyrosine Kinase Receptor or gp140trk or p140 TrkA or NTRK1 or EC 2.7.10.1) -...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0410TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0410TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016

    Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0400TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0400TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016

    Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor 4 (CD334 or FGFR4 or EC 2.7.10.1) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0398TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0398TDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer - Pipeline Review, H2 2016

    Anaplastic Thyroid Cancer - Pipeline Review, H2 2016


    2016-07-20
    ‘Anaplastic Thyroid Cancer - Pipeline Review, H2 2016’, provides an overview of the Anaplastic Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anaplastic Thyroid Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8246IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8246IDB
  • View Report: Research and Experts Market Report: Mumps - Pipeline Review, H2 2016

    Mumps - Pipeline Review, H2 2016


    2016-07-20
    ‘Mumps - Pipeline Review, H2 2016’, provides an overview of the Mumps pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by stage of development, drug target,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8243IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8243IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Alcoholic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8327IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8327IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2016

    Diabetic Neuropathic Pain - Pipeline Review, H2 2016


    2016-07-27
    ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Neuropathic...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8307IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8307IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H2 2016

    Fibromyalgia - Pipeline Review, H2 2016


    2016-07-20
    ‘Fibromyalgia - Pipeline Review, H2 2016’, provides an overview of the Fibromyalgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fibromyalgia, complete with analysis by stage of...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8279IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8279IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H2 2016

    Thromboembolism - Pipeline Review, H2 2016


    2016-07-20
    ‘Thromboembolism - Pipeline Review, H2 2016’, provides an overview of the Thromboembolism pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thromboembolism, complete with analysis by...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8289IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8289IDB
  • View Report: Research and Experts Company Report: Kowa Company, Ltd. - Strategic SWOT Analysis Review

    Kowa Company, Ltd. - Strategic SWOT Analysis Review


    2016-08-09
    Kowa Company, Ltd. (Kowa) is a global enterprise that develops and manufactures various products. It carries out the manufacturing of over the counter (OTC) products, ethical drugs and medical equipment; import and export of LED lighting equipment, optica...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 01B4-GDPH30783SA has a star rating of 4.1 out of 5
  • Go to More information on Report 01B4-GDPH30783SA
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016

    Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3527CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3527CTIDB
  • View Report: Research and Experts Market Report: DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2016

    DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘DNA Gyrase Subunit B (EC 5.99.1.3) - Pipeline Review, H1 2016’, provides in depth analysis on DNA Gyrase Subunit B (EC 5.99.1.3) targeted pipeline therapeutics.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0256TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0256TDB
  • View Report: Research and Experts Market Report: Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review,...

    Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Ephrin Type A Receptor 2 (Epithelial Cell Kinase or Tyrosine Protein Kinase Receptor ECK or EPHA2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Ephrin Type A Receptor 2 (Epithelial...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0229TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0229TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3...

    Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0221TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0221TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (I-Kappa B Kinase Beta or Nuclear Factor NF-Kappa-B Inhibitor Kinase Beta...

    Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (I-Kappa B Kinase Beta or Nuclear Factor NF-Kappa-B Inhibitor Kinase Beta or IKBKB or I-Kappa-B Kinase 2 or IKK2 or NFKBIKB or EC 2.7.11.10) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta (I-Kappa B Kinase Beta or Nuclear Factor NF-Kappa-B Inhibitor Kinase Beta or IKBKB or I-Kappa-B Kinase 2 or IKK2 or NFKBIKB or EC 2.7.11.10) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0164TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0164TDB
  • View Report: Research and Experts Market Report: Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016

    Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2016’, provides in depth analysis on Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0147TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0147TDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2016

    Neuropathic Pain - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Neuropathic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7966IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7966IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC...

    Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016’, provides in depth analysis on Proprotein Convertase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0250TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0250TDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016

    Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Hyperphosphatemia In Chronic Kidney Disease - Pipeline Review, H1 2016’, provides an overview of the Hyperphosphatemia In Chronic Kidney Disease pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Unassigned
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8189IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8189IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Brenner Tumor Global Clinical Trials Review, H1, 2016

    Brenner Tumor Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Brenner Tumor Global Clinical Trials Review, H1, 2016" provides an overview of Brenner Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on Brenner Tumor....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3471CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3471CTIDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016

    Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Rhabdomyosarcoma Global Clinical Trials Review, H1, 2016" provides an overview of Rhabdomyosarcoma clinical trials scenario. This report provides top line data relating to the clinical trials on Rhabdomyosarc...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3416CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3416CTIDB
  • View Report: Research and Experts Market Report: Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016

    Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Anemia in Chronic Kidney Disease (Renal Anemia) - Pipeline Review, H1 2016’, provides an overview of the Anemia in Chronic Kidney Disease (Renal Anemia) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8171IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8171IDB
  • View Report: Research and Experts Market Report: Pertussis (Whooping Cough) - Pipeline Review, H1 2016

    Pertussis (Whooping Cough) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Pertussis (Whooping Cough) - Pipeline Review, H1 2016’, provides an overview of the Pertussis (Whooping Cough) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8170IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8170IDB
  • View Report: Research and Experts Market Report: Bacterial Pneumonia - Pipeline Review, H1 2016

    Bacterial Pneumonia - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Bacterial Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Bacterial Pneumonia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bacterial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8164IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8164IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H1 2016

    Liposarcoma - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2016’, provides an overview of the Liposarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liposarcoma , complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8206IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8206IDB
  • View Report: Research and Experts Market Report: Poliomyelitis - Pipeline Review, H1 2016

    Poliomyelitis - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Poliomyelitis - Pipeline Review, H1 2016’, provides an overview of the Poliomyelitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Poliomyelitis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8182IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8182IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H1 2016

    Neuroendocrine Tumors - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2016’, provides an overview of the Neuroendocrine Tumors pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8174IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8174IDB
  • View Report: Research and Experts Market Report: Streptococcal Pneumonia - Pipeline Review, H1 2016

    Streptococcal Pneumonia - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Streptococcal Pneumonia - Pipeline Review, H1 2016’, provides an overview of the Streptococcal Pneumonia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8165IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8165IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H1 2016

    Age Related Macular Degeneration - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related Macular Degeneration pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7973IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7973IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Cancer Pain - Pipeline Review, H1 2016

    Cancer Pain - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2016’, provides an overview of the Cancer Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cancer Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8020IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8020IDB
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016

    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2016’, provides an overview of the H5N1 Infection (Avian Influenza) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8005IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8005IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Stroke - Pipeline Review, H1 2016

    Stroke - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Stroke - Pipeline Review, H1 2016’, provides an overview of the Stroke pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Stroke, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7975IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7975IDB
  • View Report: Research and Experts Market Report: Transmembrane Prolyl 4-Hydroxylase (Hypoxia-Inducible Factor Prolyl Hydroxylase 4 or EC 1.14.11.) - Pipeline Review, H1 2016

    Transmembrane Prolyl 4-Hydroxylase (Hypoxia-Inducible Factor Prolyl Hydroxylase 4 or EC 1.14.11.) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Transmembrane Prolyl 4-Hydroxylase (Hypoxia-Inducible Factor Prolyl Hydroxylase 4 or EC 1.14.11.) - Pipeline Review, H1 2016’, provides in depth analysis on Transmembrane Prolyl 4-Hydroxylase (Hypoxia-Inducible...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0039TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0039TDB
  • View Report: Research and Experts Market Report: Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016

    Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016’, provides in depth analysis on Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) targeted pipeline therapeutics.

    The report provides...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0038TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0038TDB
  • View Report: Research and Experts Market Report: Diphtheria - Pipeline Review, H1 2016

    Diphtheria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2016’, provides an overview of the Diphtheria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diphtheria, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8037IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8037IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2016

    Malaria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2016’, provides an overview of the Malaria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7969IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7969IDB
  • View Report: Research and Experts Market Report: Rubella - Pipeline Review, H1 2016

    Rubella - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Rubella - Pipeline Review, H1 2016’, provides an overview of the Rubella pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rubella, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8053IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8053IDB
  • View Report: Research and Experts Market Report: Atherosclerosis - Pipeline Review, H1 2016

    Atherosclerosis - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Atherosclerosis - Pipeline Review, H1 2016’, provides an overview of the Atherosclerosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atherosclerosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7993IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7993IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2016

    Osteoporosis - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2016’, provides an overview of the Osteoporosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoporosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7989IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7989IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease Global Clinical Trials Review, H1, 2016

    Sickle Cell Disease Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Sickle Cell Disease Global Clinical Trials Review, H1, 2016" provides an overview of Sickle Cell Disease clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3380CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3380CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections - Pipeline Review, H1 2016

    Haemophilus influenzae Type B Infections - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Haemophilus influenzae Type B Infections - Pipeline Review, H1 2016’, provides an overview of the Haemophilus influenzae Type B Infections pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8045IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8045IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016

    Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) - Pipeline Review, H1 2016’, provides in depth analysis on Free Fatty Acid Receptor 1 (G-Protein Coupled Receptor 40 or FFAR1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0002TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0002TDB
  • View Report: Research and Experts Market Report: Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016

    Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor 119 or GPR119) - Pipeline Review, H1 2016’, provides in depth analysis on Glucose-Dependent Insulinotropic Receptor (G-Protein Coupled Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0001TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0001TDB
  • View Report: Research and Experts Market Report: Measles - Pipeline Review, H1 2016

    Measles - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Measles - Pipeline Review, H1 2016’, provides an overview of the Measles pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Measles, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7870IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7870IDB
  • View Report: Research and Experts Market Report: Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2016

    Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2016’, provides an overview of the Clostridium difficile Infections (Clostridium difficile Associated Disease) pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7821IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7821IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Poliomyelitis Global Clinical Trials Review, H1, 2016

    Poliomyelitis Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Poliomyelitis Global Clinical Trials Review, H1, 2016" provides an overview of Poliomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Poliomyelitis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3336CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3336CTIDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7688IDB
  • View Report: Research and Experts Market Report: Bacterial Conjunctivitis - Pipeline Review, H1 2016

    Bacterial Conjunctivitis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Bacterial Conjunctivitis - Pipeline Review, H1 2016’, provides an overview of the Bacterial Conjunctivitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7911IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7911IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H1 2016

    Postherpetic Neuralgia - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7853IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7853IDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke - Pipeline Review, H1 2016

    Acute Ischemic Stroke - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H1 2016’, provides an overview of the Acute Ischemic Stroke pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7851IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7851IDB
  • View Report: Research and Experts Market Report: Tetanus - Pipeline Review, H1 2016

    Tetanus - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Tetanus - Pipeline Review, H1 2016’, provides an overview of the Tetanus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tetanus, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7837IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7837IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2016

    Chronic Pain - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2016’, provides an overview of the Chronic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Chronic Pain, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7690IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7690IDB
  • View Report: Research and Experts Industry Report: Daiichi Sankyo Company, Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Daiichi Sankyo Company, Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Unassigned
  • Japan
  • $350.00
  • Report 05IK-2A249A7B-D582-41EB-9F97-7B has a star rating of 4.4 out of 5
  • Go to More information on Report 05IK-2A249A7B-D582-41EB-9F97-7B
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2016’, provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7744IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7744IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2016

    Dyslipidemia - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2016’, provides an overview of the Dyslipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dyslipidemia, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7652IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7652IDB
  • View Report: Research and Experts Market Report: Cancer Pain Global Clinical Trials Review, H1, 2016

    Cancer Pain Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2016" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3297CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3297CTIDB
  • View Report: Research and Experts Market Report: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7702IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7702IDB
  • View Report: Research and Experts Company Report: CSL Limited (CSL) - Medical Equipment - Deals and Alliances Profile

    CSL Limited (CSL) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    CSL Limited (CSL) is a specialty biotherapeutics company that carries out research and development, manufacturing, marketing and distribution of biopharmaceutical and related products. Its product portfolio include plasma-derived products for treating...
  • Company Report
  • Medical Devices
  • Australia
  • $250.00
  • Report 05IB-GDME66579D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME66579D
  • View Report: Research and Experts Company Report: Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile

    Astellas Pharma Inc. (4503) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Report
  • Medical Devices
  • Japan
  • $250.00
  • Report 05IB-GDME27458D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME27458D
  • View Report: Research and Experts Market Report: Hyperlipidemia - Pipeline Review, H1 2016

    Hyperlipidemia - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Hyperlipidemia - Pipeline Review, H1 2016’, provides an overview of the Hyperlipidemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperlipidemia,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7653IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7653IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7604IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7604IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H1 2016

    Constipation - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2016’, provides an overview of the Constipation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Constipation, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7594IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7594IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2016

    Diabetic Neuropathic Pain - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7576IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7576IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H1 2016

    Atrial Fibrillation - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2016’, provides an overview of the Atrial Fibrillation pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Atrial...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7550IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7550IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H1 2016

    Fibromyalgia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2016’, provides an overview of the Fibromyalgia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Fibromyalgia, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7575IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7575IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H1 2016

    Thromboembolism - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2016’, provides an overview of the Thromboembolism pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thromboembolism,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7556IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7556IDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer - Pipeline Review, H1 2016

    Anaplastic Thyroid Cancer - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7670IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7670IDB
  • View Report: Research and Experts Market Report: Mumps - Pipeline Review, H1 2016

    Mumps - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Mumps - Pipeline Review, H1 2016’, provides an overview of the Mumps pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Mumps, complete with analysis by...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7641IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7641IDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H1, 2016

    Venous Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3233CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3233CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H1, 2016

    Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3232CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3232CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Sjögren

    OpportunityAnalyzer: Sjögren's Syndrome - Opportunity Analysis and Forecast to 2024


    2015-12-19
    Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary glands, resulting...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC048POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC048POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Hepatocellular Carcinoma - Opportunity Analysis and Forecasts to 2024


    2015-12-17
    Liver cancer is the second leading cause of cancer related death in the world in men and the sixth leading cause of cancer death in women. Hepatocellular carcinoma (HCC) is the most dominant form of liver cancer, accounting for approximately 85% of liver...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC046POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC046POA
  • View Report: Research and Experts Market Report: Thromboembolic Disease Global Clinical Trials Review, H1, 2016

    Thromboembolic Disease Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Thromboembolic Disease Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3217CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3217CTIDB
  • View Report: Research and Experts Market Report: Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016

    Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Neuroendocrine Carcinoma Global Clinical Trials Review, H1, 2016" provides an overview of Neuroendocrine Carcinoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3215CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3215CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024


    2015-12-01
    Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC051POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC051POA
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016

    H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016" provides an overview of H5N1 Infection (Avian Influenza) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3191CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3191CTIDB
  • View Report: Research and Experts Market Report: Influenza A Infections Global Clinical Trials Review, H1, 2016

    Influenza A Infections Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Influenza A Infections Global Clinical Trials Review, H1, 2016" provides an overview of Influenza A Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3190CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3190CTIDB
  • View Report: Research and Experts Market Report: Influenza B Infections Global Clinical Trials Review, H1, 2016

    Influenza B Infections Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Influenza B Infections Global Clinical Trials Review, H1, 2016" provides an overview of Influenza B Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3186CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3186CTIDB
  • View Report: Research and Experts Market Report: Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015

    Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mycobacterium avium-Intracellulare Infections Global Clinical Trials Review, H2, 2015" provides an overview of Mycobacterium avium-Intracellulare Infections clinical trials scenario. This report provides...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3184CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3184CTIDB
  • View Report: Research and Experts Market Report: Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015

    Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Complicated Skin And Skin Structure Infections (cSSSI) Global Clinical Trials Review, H2, 2015" provides an overview of Complicated Skin And Skin Structure Infections (cSSSI) clinical trials scenario....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3183CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3183CTIDB
  • View Report: Research and Experts Market Report: Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015

    Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chlamydia trachomatis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Chlamydia trachomatis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3182CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3182CTIDB
  • View Report: Research and Experts Market Report: Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015

    Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Skin And Skin Structure Infections (SSSI) Caused By Bacteria Global Clinical Trials Review, H2, 2015" provides an overview of Skin And Skin Structure Infections (SSSI) Caused By Bacteria clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3181CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3181CTIDB
  • View Report: Research and Experts Market Report: Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015

    Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Staphylococcus aureus Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3180CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3180CTIDB
  • View Report: Research and Experts Market Report: Streptococcal Infections Global Clinical Trials Review, H2, 2015

    Streptococcal Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2015" provides an overview of Streptococcal Infections clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3179CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3179CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3178CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3178CTIDB
  • View Report: Research and Experts Market Report: Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015

    Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pseudomonas aeruginosa Infections Global Clinical Trials Review, H2, 2015" provides an overview of Pseudomonas aeruginosa Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3177CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3177CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015

    Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Haemophilus influenzae Type B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Haemophilus influenzae Type B Infections clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3176CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3176CTIDB
  • View Report: Research and Experts Market Report: Rotavirus Infections Global Clinical Trials Review, H2, 2015

    Rotavirus Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rotavirus Infections Global Clinical Trials Review, H2, 2015" provides an overview of Rotavirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3175CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3175CTIDB
  • View Report: Research and Experts Market Report: Influenza B Infections Global Clinical Trials Review, H2, 2015

    Influenza B Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza B Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza B Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3174CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3174CTIDB
  • View Report: Research and Experts Market Report: Pandemic Influenza Global Clinical Trials Review, H2, 2015

    Pandemic Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pandemic Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3173CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3173CTIDB
  • View Report: Research and Experts Market Report: Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

    Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015" provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3172CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3172CTIDB
  • View Report: Research and Experts Market Report: Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015

    Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Neisseria meningitidis Infections Global Clinical Trials Review, H2, 2015" provides an overview of Neisseria meningitidis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3171CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3171CTIDB
  • View Report: Research and Experts Market Report: Influenza A Infections Global Clinical Trials Review, H2, 2015

    Influenza A Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Influenza A Infections Global Clinical Trials Review, H2, 2015" provides an overview of Influenza A Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3170CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3170CTIDB
  • View Report: Research and Experts Market Report: Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015

    Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Bacterial Prostatitis Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Bacterial Prostatitis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3169CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3169CTIDB
  • View Report: Research and Experts Market Report: Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015

    Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Epstein-Barr Viral Infections Global Clinical Trials Review, H2, 2015" provides an overview of Epstein-Barr Viral Infections clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3168CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3168CTIDB
  • View Report: Research and Experts Market Report: Clostridium Infections Global Clinical Trials Review, H2, 2015

    Clostridium Infections Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Clostridium Infections Global Clinical Trials Review, H2, 2015" provides an overview of Clostridium Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3167CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3167CTIDB
  • View Report: Research and Experts Market Report: Hepatitis Global Clinical Trials Review, H2, 2015

    Hepatitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3166CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3166CTIDB
  • View Report: Research and Experts Market Report: Seasonal Influenza Global Clinical Trials Review, H2, 2015

    Seasonal Influenza Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Seasonal Influenza Global Clinical Trials Review, H2, 2015" provides an overview of Seasonal Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3165CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3165CTIDB
  • View Report: Research and Experts Market Report: Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015

    Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hand, Foot And Mouth Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hand, Foot And Mouth Disease clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3164CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3164CTIDB
  • View Report: Research and Experts Market Report: Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015

    Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hemophagocytic Lymphohistiocytosis Global Clinical Trials Review, H2, 2015" provides an overview of Hemophagocytic Lymphohistiocytosis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3163CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3163CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2015

    Osteoarthritis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2015" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3162CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3162CTIDB
  • View Report: Research and Experts Market Report: Measles Global Clinical Trials Review, H2, 2015

    Measles Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Measles Global Clinical Trials Review, H2, 2015" provides an overview of Measles clinical trials scenario. This report provides top line data relating to the clinical trials on Measles. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3161CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3161CTIDB
  • View Report: Research and Experts Market Report: Brucellosis Global Clinical Trials Review, H2, 2015

    Brucellosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Brucellosis Global Clinical Trials Review, H2, 2015" provides an overview of Brucellosis clinical trials scenario. This report provides top line data relating to the clinical trials on Brucellosis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3160CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3160CTIDB
  • View Report: Research and Experts Market Report: Vaginitis Global Clinical Trials Review, H2, 2015

    Vaginitis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Vaginitis Global Clinical Trials Review, H2, 2015" provides an overview of Vaginitis clinical trials scenario. This report provides top line data relating to the clinical trials on Vaginitis. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3159CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3159CTIDB
  • View Report: Research and Experts Market Report: Mumps Global Clinical Trials Review, H2, 2015

    Mumps Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Mumps Global Clinical Trials Review, H2, 2015" provides an overview of Mumps clinical trials scenario. This report provides top line data relating to the clinical trials on Mumps. Report includes an...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3158CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3158CTIDB
  • View Report: Research and Experts Market Report: Rubella Global Clinical Trials Review, H2, 2015

    Rubella Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Rubella Global Clinical Trials Review, H2, 2015" provides an overview of Rubella clinical trials scenario. This report provides top line data relating to the clinical trials on Rubella. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3157CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3157CTIDB
  • View Report: Research and Experts Market Report: Corneal Graft Rejection Global Clinical Trials Review, H2, 2015

    Corneal Graft Rejection Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Corneal Graft Rejection Global Clinical Trials Review, H2, 2015" provides an overview of Corneal Graft Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3156CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3156CTIDB
  • View Report: Research and Experts Market Report: Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015

    Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H2, 2015" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3155CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3155CTIDB
  • View Report: Research and Experts Market Report: Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015

    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Global Clinical Trials Review, H2, 2015" provides an overview of Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency)...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3154CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3154CTIDB
  • View Report: Research and Experts Market Report: Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015

    Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2015" provides an overview of Hematopoietic Stem Cell Transplantation clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3153CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3153CTIDB
  • View Report: Research and Experts Market Report: Allergies Global Clinical Trials Review, H2, 2015

    Allergies Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Allergies Global Clinical Trials Review, H2, 2015" provides an overview of Allergies clinical trials scenario. This report provides top line data relating to the clinical trials on Allergies. Report...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3152CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3152CTIDB
  • View Report: Research and Experts Market Report: Chronic Inflammation Global Clinical Trials Review, H2, 2015

    Chronic Inflammation Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3151CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3151CTIDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H2, 2015

    Myelofibrosis Global Clinical Trials Review, H2, 2015


    2015-12-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H2, 2015" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3150CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3150CTIDB
  • View Report: Research and Experts Market Report: Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015

    Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015


    2015-10-30
    Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2015’, provides an overview of the Recurrent...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7252IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7252IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H2 2015

    Postherpetic Neuralgia - Pipeline Review, H2 2015


    2015-10-30
    Postherpetic Neuralgia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H2 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7240IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7240IDB
  • View Report: Research and Experts Market Report: Renal Anemia - Pipeline Review, H2 2015

    Renal Anemia - Pipeline Review, H2 2015


    2015-10-30
    Renal Anemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Renal Anemia - Pipeline Review, H2 2015’, provides an overview of the Renal Anemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7230IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7230IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2015

    Cervical Cancer - Pipeline Review, H2 2015


    2015-10-30
    Cervical Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H2 2015’, provides an overview of the Cervical Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7210IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7210IDB
  • View Report: Research and Experts Market Report: Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2015

    Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2015


    2015-10-28
    Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2015’,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7280IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7280IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H2 2015

    Esophageal Cancer - Pipeline Review, H2 2015


    2015-10-21
    Esophageal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6962IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6962IDB
  • View Report: Research and Experts Market Report: Pertussis - Pipeline Review, H2 2015

    Pertussis - Pipeline Review, H2 2015


    2015-10-21
    Pertussis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Pertussis - Pipeline Review, H2 2015’, provides an overview of the Pertussis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6849IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6849IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015


    2015-10-21
    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6840IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6840IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Diabetic Neuropathic Pain - Pipeline Review, H2 2015


    2015-10-14
    Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6858IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6858IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H2 2015

    Atrial Fibrillation - Pipeline Review, H2 2015


    2015-10-14
    Atrial Fibrillation - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H2 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6854IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6854IDB
  • View Report: Research and Experts Market Report: Ischemic Stroke - Pipeline Review, H2 2015

    Ischemic Stroke - Pipeline Review, H2 2015


    2015-09-30
    Ischemic Stroke - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Ischemic Stroke - Pipeline Review, H2 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7071IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7071IDB
  • View Report: Research and Experts Market Report: Tetanus - Pipeline Review, H2 2015

    Tetanus - Pipeline Review, H2 2015


    2015-09-23
    Tetanus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2015’, provides an overview of the Tetanus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7091IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7091IDB
  • View Report: Research and Experts Market Report: Seasonal Influenza - Pipeline Review, H2 2015

    Seasonal Influenza - Pipeline Review, H2 2015


    2015-09-23
    Seasonal Influenza - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Seasonal Influenza - Pipeline Review, H2 2015’, provides an overview of the Seasonal Influenza’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7080IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7080IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H2 2015

    Liposarcoma - Pipeline Review, H2 2015


    2015-09-09
    Liposarcoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H2 2015’, provides an overview of the Liposarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7131IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7131IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H2 2015

    Fibromyalgia - Pipeline Review, H2 2015


    2015-08-26
    Fibromyalgia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H2 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6997IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6997IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H2 2015

    Thromboembolism - Pipeline Review, H2 2015


    2015-07-31
    Thromboembolism - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H2 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6873IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6873IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H2 2015

    Constipation - Pipeline Review, H2 2015


    2015-07-31
    Constipation - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Constipation - Pipeline Review, H2 2015’, provides an overview of the Constipation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6864IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6864IDB
  • View Report: Research and Experts Market Report: High Triglyceridemia - Pipeline Review, H2 2015

    High Triglyceridemia - Pipeline Review, H2 2015


    2015-07-31
    High Triglyceridemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘High Triglyceridemia - Pipeline Review, H2 2015’, provides an overview of the High Triglyceridemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6859IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6859IDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke - Pipeline Review, H2 2015

    Acute Ischemic Stroke - Pipeline Review, H2 2015


    2015-07-29
    Acute Ischemic Stroke - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H2 2015’, provides an overview of the Acute Ischemic Stroke’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6937IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6937IDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer - Pipeline Review, H2 2015

    Anaplastic Thyroid Cancer - Pipeline Review, H2 2015


    2015-07-22
    Anaplastic Thyroid Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Pipeline Review, H2 2015’, provides an overview of the Anaplastic Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6897IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6897IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6509IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6509IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2015

    Malaria - Pipeline Review, H1 2015


    2015-06-30
    Malaria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6677IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6677IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2015

    Tuberculosis - Pipeline Review, H1 2015


    2015-06-30
    Tuberculosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6566IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6566IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Staphylococcus Aureus Infections - Pipeline Review, H1 2015

    Staphylococcus Aureus Infections - Pipeline Review, H1 2015


    2015-06-30
    Staphylococcus Aureus Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Staphylococcus Aureus Infections - Pipeline Review, H1 2015’, provides an overview of the Staphylococcus Aureus Infections’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6564IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6564IDB
  • View Report: Research and Experts Market Report: Thrombosis - Pipeline Review, H1 2015

    Thrombosis - Pipeline Review, H1 2015


    2015-06-30
    Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6511IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6511IDB
  • View Report: Research and Experts Market Report: Stroke - Pipeline Review, H1 2015

    Stroke - Pipeline Review, H1 2015


    2015-06-30
    Stroke - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Stroke - Pipeline Review, H1 2015’, provides an overview of the Stroke’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6493IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6493IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H1 2015

    Colon Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colon Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2015’, provides an overview of the Colon Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6678IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6678IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Osteoporosis - Pipeline Review, H1 2015

    Osteoporosis - Pipeline Review, H1 2015


    2015-06-30
    Osteoporosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H1 2015’, provides an overview of the Osteoporosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6572IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6572IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H1 2015

    Cervical Cancer - Pipeline Review, H1 2015


    2015-06-30
    Cervical Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2015’, provides an overview of the Cervical Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6517IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6517IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6516IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6516IDB
  • View Report: Research and Experts Market Report: Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015

    Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015


    2015-06-30
    Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Streptococcus Pneumoniae Infection - Pipeline Review, H1 2015’, provides an overview of the Streptococcus Pneumoniae Infection’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6500IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6500IDB
  • View Report: Research and Experts Market Report: Cancer Pain - Pipeline Review, H1 2015

    Cancer Pain - Pipeline Review, H1 2015


    2015-06-24
    Cancer Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cancer Pain - Pipeline Review, H1 2015’, provides an overview of the Cancer Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6696IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6696IDB
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015


    2015-06-24
    H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘H5N1 Infection (Avian Influenza) - Pipeline Review, H1 2015’, provides an overview of the H5N1 Infection (Avian Influenza)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6689IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6689IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Diphtheria - Pipeline Review, H1 2015

    Diphtheria - Pipeline Review, H1 2015


    2015-06-10
    Diphtheria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2015’, provides an overview of the Diphtheria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6707IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6707IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2015

    Endometrial Cancer - Pipeline Review, H1 2015


    2015-05-29
    Endometrial Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6584IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6584IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H1 2015

    Sickle Cell Disease - Pipeline Review, H1 2015


    2015-05-29
    Sickle Cell Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6583IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6583IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015

    Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015


    2015-05-29
    Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H1 2015’,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6578IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6578IDB
  • View Report: Research and Experts Market Report: Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015

    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015


    2015-05-29
    Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2015’, provides an overview of the Gastrointestinal Stromal Tumor (GIST)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6594IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6594IDB
  • View Report: Research and Experts Market Report: Renal Anemia - Pipeline Review, H1 2015

    Renal Anemia - Pipeline Review, H1 2015


    2015-05-29
    Renal Anemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Anemia - Pipeline Review, H1 2015’, provides an overview of the Renal Anemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6535IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6535IDB
  • View Report: Research and Experts Market Report: Cardiac Fibrosis - Pipeline Review, H1 2015

    Cardiac Fibrosis - Pipeline Review, H1 2015


    2015-05-20
    Cardiac Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cardiac Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Cardiac Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6734IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6734IDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke - Pipeline Review, H1 2015

    Acute Ischemic Stroke - Pipeline Review, H1 2015


    2015-04-30
    Acute Ischemic Stroke - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Acute Ischemic Stroke’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6599IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6599IDB
  • View Report: Research and Experts Market Report: Postherpetic Neuralgia - Pipeline Review, H1 2015

    Postherpetic Neuralgia - Pipeline Review, H1 2015


    2015-04-30
    Postherpetic Neuralgia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Postherpetic Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Postherpetic Neuralgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6546IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6546IDB
  • View Report: Research and Experts Market Report: Bacterial Conjunctivitis - Pipeline Review, H1 2015

    Bacterial Conjunctivitis - Pipeline Review, H1 2015


    2015-04-29
    Bacterial Conjunctivitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bacterial Conjunctivitis - Pipeline Review, H1 2015’, provides an overview of the Bacterial Conjunctivitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6631IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6631IDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism - Pipeline Review, H1 2015

    Venous Thromboembolism - Pipeline Review, H1 2015


    2015-04-29
    Venous Thromboembolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Venous Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Venous Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6627IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6627IDB
  • View Report: Research and Experts Market Report: Ischemic Stroke - Pipeline Review, H1 2015

    Ischemic Stroke - Pipeline Review, H1 2015


    2015-03-31
    Ischemic Stroke - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ischemic Stroke - Pipeline Review, H1 2015’, provides an overview of the Ischemic Stroke’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6244IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6244IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015


    2015-03-31
    Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic (Essential) Hypertension - Pipeline Review, H1 2015’, provides an overview of the Idiopathic (Essential) Hypertension’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6418IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6418IDB
  • View Report: Research and Experts Market Report: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-03-26
    Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Recurrent...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6414IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6414IDB
  • View Report: Research and Experts Market Report: Pulmonary Embolism - Pipeline Review, H1 2015

    Pulmonary Embolism - Pipeline Review, H1 2015


    2015-03-19
    Pulmonary Embolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Embolism - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Embolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6447IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6447IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Dermatitis - Pipeline Review, H1 2015

    Dermatitis - Pipeline Review, H1 2015


    2015-03-19
    Dermatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dermatitis - Pipeline Review, H1 2015’, provides an overview of the Dermatitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6240IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6240IDB
  • View Report: Research and Experts Market Report: Tetanus - Pipeline Review, H1 2015

    Tetanus - Pipeline Review, H1 2015


    2015-03-11
    Tetanus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tetanus - Pipeline Review, H1 2015’, provides an overview of the Tetanus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6264IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6264IDB
  • View Report: Research and Experts Market Report: Cough - Pipeline Review, H1 2015

    Cough - Pipeline Review, H1 2015


    2015-02-24
    Cough - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cough - Pipeline Review, H1 2015’, provides an overview of the Cough’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6352IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6352IDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H1 2015

    Liposarcoma - Pipeline Review, H1 2015


    2015-02-18
    Liposarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2015’, provides an overview of the Liposarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6305IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6305IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Chronic Pain - Pipeline Review, H1 2015

    Chronic Pain - Pipeline Review, H1 2015


    2015-02-10
    Chronic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6129IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6129IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2015

    Esophageal Cancer - Pipeline Review, H1 2015


    2015-01-30
    Esophageal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6140IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6140IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H1 2015

    Diabetic Nephropathy - Pipeline Review, H1 2015


    2015-01-30
    Diabetic Nephropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Diabetic Nephropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6138IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6138IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015


    2015-01-30
    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6134IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6134IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015


    2015-01-30
    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015’, provides an overview of the Chronic Obstructive Pulmonary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6009IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6009IDB
  • View Report: Research and Experts Market Report: Fibromyalgia - Pipeline Review, H1 2015

    Fibromyalgia - Pipeline Review, H1 2015


    2015-01-30
    Fibromyalgia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fibromyalgia - Pipeline Review, H1 2015’, provides an overview of the Fibromyalgia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6175IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6175IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Anaplastic Thyroid Cancer - Pipeline Review, H1 2015

    Anaplastic Thyroid Cancer - Pipeline Review, H1 2015


    2015-01-22
    Anaplastic Thyroid Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6083IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6083IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H1 2015

    Thromboembolism - Pipeline Review, H1 2015


    2015-01-22
    Thromboembolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6059IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6059IDB
  • View Report: Research and Experts Market Report: Constipation - Pipeline Review, H1 2015

    Constipation - Pipeline Review, H1 2015


    2015-01-22
    Constipation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Constipation - Pipeline Review, H1 2015’, provides an overview of the Constipation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6050IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6050IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2015

    Diabetic Neuropathic Pain - Pipeline Review, H1 2015


    2015-01-22
    Diabetic Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6044IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6044IDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation - Pipeline Review, H1 2015

    Atrial Fibrillation - Pipeline Review, H1 2015


    2015-01-22
    Atrial Fibrillation - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6040IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6040IDB
  • View Report: Research and Experts Market Report: Pertussis - Pipeline Review, H1 2015

    Pertussis - Pipeline Review, H1 2015


    2015-01-22
    Pertussis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2015’, provides an overview of the Pertussis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6035IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6035IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

    Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015


    2015-01-22
    Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H1 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6026IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6026IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2015

    Dyslipidemia - Pipeline Review, H1 2015


    2015-01-22
    Dyslipidemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6020IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6020IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Market Report: HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015

    HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “HIV-Associated Lipodystrophy Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of HIV-Associated Lipodystrophy Syndrome clinical trials scenario. This report provides top line data...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3149CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3149CTIDB
  • View Report: Research and Experts Market Report: Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015

    Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Lysosomal Storage Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Lysosomal Storage Disorder clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3148CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3148CTIDB
  • View Report: Research and Experts Market Report: Cardiometabolic Disease Global Clinical Trials Review, H2, 2015

    Cardiometabolic Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Cardiometabolic Disease Global Clinical Trials Review, H2, 2015" provides an overview of Cardiometabolic Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3147CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3147CTIDB
  • View Report: Research and Experts Market Report: Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015

    Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Homozygous Familial Hypercholesterolemia (HoFH) Global Clinical Trials Review, H2, 2015" provides an overview of Homozygous Familial Hypercholesterolemia (HoFH) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3146CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3146CTIDB
  • View Report: Research and Experts Market Report: Diabetic Complications Global Clinical Trials Review, H2, 2015

    Diabetic Complications Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Diabetic Complications Global Clinical Trials Review, H2, 2015" provides an overview of Diabetic Complications clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3145CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3145CTIDB
  • View Report: Research and Experts Market Report: Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015

    Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H2, 2015" provides an overview of Hepatic Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3144CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3144CTIDB
  • View Report: Research and Experts Market Report: Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015

    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) Global Clinical Trials Review, H2, 2015" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3143CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3143CTIDB
  • View Report: Research and Experts Market Report: Urea Cycle Disorders Global Clinical Trials Review, H2, 2015

    Urea Cycle Disorders Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Urea Cycle Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Urea Cycle Disorders clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3142CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3142CTIDB
  • View Report: Research and Experts Market Report: Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015

    Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Heterozygous familial hypercholesterolemia (heFH) Global Clinical Trials Review, H2, 2015" provides an overview of Heterozygous familial hypercholesterolemia (heFH) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3141CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3141CTIDB
  • View Report: Research and Experts Market Report: Lipid Disorders Global Clinical Trials Review, H2, 2015

    Lipid Disorders Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Lipid Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Lipid Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Lipid...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3140CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3140CTIDB
  • View Report: Research and Experts Market Report: Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015

    Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Tendon and Ligament Pain Global Clinical Trials Review, H2, 2015" provides an overview of Tendon and Ligament Pain clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3139CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3139CTIDB
  • View Report: Research and Experts Market Report: Visceral Pain Global Clinical Trials Review, H2, 2015

    Visceral Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Visceral Pain Global Clinical Trials Review, H2, 2015" provides an overview of Visceral Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Visceral Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3138CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3138CTIDB
  • View Report: Research and Experts Market Report: Treatment Resistant Depression Global Clinical Trials Review, H2, 2015

    Treatment Resistant Depression Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Treatment Resistant Depression Global Clinical Trials Review, H2, 2015" provides an overview of Treatment Resistant Depression clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3137CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3137CTIDB
  • View Report: Research and Experts Market Report: Resistant Hypertension Global Clinical Trials Review, H2, 2015

    Resistant Hypertension Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Resistant Hypertension Global Clinical Trials Review, H2, 2015" provides an overview of Resistant Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3136CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3136CTIDB
  • View Report: Research and Experts Market Report: Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015

    Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Post-Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Post-Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3135CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3135CTIDB
  • View Report: Research and Experts Market Report: Thromboembolic Disease Global Clinical Trials Review, H2, 2015

    Thromboembolic Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Thromboembolic Disease Global Clinical Trials Review, H2, 2015" provides an overview of Thromboembolic Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3134CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3134CTIDB
  • View Report: Research and Experts Market Report: Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015

    Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Vaso-Occlusive Crisis Associated With Sickle Cell Disease Global Clinical Trials Review, H2, 2015" provides an overview of Vaso-Occlusive Crisis Associated With Sickle Cell Disease clinical trials scenario....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3133CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3133CTIDB
  • View Report: Research and Experts Market Report: Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015

    Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015" provides an overview of Percutaneous Coronary Intervention clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3132CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3132CTIDB
  • View Report: Research and Experts Market Report: Systolic Heart Failure Global Clinical Trials Review, H2, 2015

    Systolic Heart Failure Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Systolic Heart Failure Global Clinical Trials Review, H2, 2015" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3131CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3131CTIDB
  • View Report: Research and Experts Market Report: Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015

    Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Patent Ductus Arteriosus Global Clinical Trials Review, H2, 2015" provides an overview of Patent Ductus Arteriosus clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3130CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3130CTIDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015

    Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H2, 2015" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3129CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3129CTIDB
  • View Report: Research and Experts Market Report: Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015

    Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hypertrophic Cardiomyopathy Global Clinical Trials Review, H2, 2015" provides an overview of Hypertrophic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3128CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3128CTIDB
  • View Report: Research and Experts Market Report: Coronary Disease Global Clinical Trials Review, H2, 2015

    Coronary Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Coronary Disease Global Clinical Trials Review, H2, 2015" provides an overview of Coronary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3127CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3127CTIDB
  • View Report: Research and Experts Market Report: Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015

    Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3126CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3126CTIDB
  • View Report: Research and Experts Market Report: Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015

    Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Non-ischemic Cardiomyopathy Global Clinical Trials Review, H2, 2015" provides an overview of Non-ischemic Cardiomyopathy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3125CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3125CTIDB
  • View Report: Research and Experts Market Report: Myocardial Infarction Global Clinical Trials Review, H2, 2015

    Myocardial Infarction Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Myocardial Infarction Global Clinical Trials Review, H2, 2015" provides an overview of Myocardial Infarction clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3124CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3124CTIDB
  • View Report: Research and Experts Market Report: Mitral Valve Diseases Global Clinical Trials Review, H2, 2015

    Mitral Valve Diseases Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Mitral Valve Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Mitral Valve Diseases clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3123CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3123CTIDB
  • View Report: Research and Experts Market Report: Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015

    Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Hepatic Veno Occlusive Disease Global Clinical Trials Review, H2, 2015" provides an overview of Hepatic Veno Occlusive Disease clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3122CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3122CTIDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015

    Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H2, 2015" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3121CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3121CTIDB
  • View Report: Research and Experts Market Report: Cardiac Arrest Global Clinical Trials Review, H2, 2015

    Cardiac Arrest Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Cardiac Arrest Global Clinical Trials Review, H2, 2015" provides an overview of Cardiac Arrest clinical trials scenario. This report provides top line data relating to the clinical trials on Cardiac...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3120CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3120CTIDB
  • View Report: Research and Experts Market Report: Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015

    Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Secondary Progressive Multiple Sclerosis (SPMS) Global Clinical Trials Review, H2, 2015" provides an overview of Secondary Progressive Multiple Sclerosis (SPMS) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3119CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3119CTIDB
  • View Report: Research and Experts Market Report: Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015

    Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Primary Progressive Multiple Sclerosis (PPMS) Global Clinical Trials Review, H2, 2015" provides an overview of Primary Progressive Multiple Sclerosis (PPMS) clinical trials scenario. This report provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3118CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3118CTIDB
  • View Report: Research and Experts Market Report: Post-Operative Pain Global Clinical Trials Review, H2, 2015

    Post-Operative Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Post-Operative Pain Global Clinical Trials Review, H2, 2015" provides an overview of Post-Operative Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3117CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3117CTIDB
  • View Report: Research and Experts Market Report: Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015

    Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Opium Withdrawal Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Opium Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3116CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3116CTIDB
  • View Report: Research and Experts Market Report: Non Malignant pain Global Clinical Trials Review, H2, 2015

    Non Malignant pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Non Malignant pain Global Clinical Trials Review, H2, 2015" provides an overview of Non Malignant pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3115CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3115CTIDB
  • View Report: Research and Experts Market Report: Musculoskeletal Pain Global Clinical Trials Review, H2, 2015

    Musculoskeletal Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Musculoskeletal Pain Global Clinical Trials Review, H2, 2015" provides an overview of Musculoskeletal Pain clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3114CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3114CTIDB
  • View Report: Research and Experts Market Report: Pathological Gambling Global Clinical Trials Review, H2, 2015

    Pathological Gambling Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Pathological Gambling Global Clinical Trials Review, H2, 2015" provides an overview of Pathological Gambling clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3113CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3113CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain Global Clinical Trials Review, H2, 2015

    Osteoarthritis Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Osteoarthritis Pain Global Clinical Trials Review, H2, 2015" provides an overview of Osteoarthritis Pain clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3112CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3112CTIDB
  • View Report: Research and Experts Market Report: Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015

    Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Neurotoxicity Syndromes Global Clinical Trials Review, H2, 2015" provides an overview of Neurotoxicity Syndromes clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3111CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3111CTIDB
  • View Report: Research and Experts Market Report: Neck Pain Global Clinical Trials Review, H2, 2015

    Neck Pain Global Clinical Trials Review, H2, 2015


    2015-12-23
    GlobalData's clinical trial report, “Neck Pain Global Clinical Trials Review, H2, 2015" provides an overview of Neck Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Neck Pain. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3110CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3110CTIDB
  • View Report: Research and Experts Market Report: Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015

    Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Cerebrospinal Venous Insufficiency (CCSVI) Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Cerebrospinal Venous Insufficiency (CCSVI) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3109CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3109CTIDB
  • View Report: Research and Experts Market Report: Low Back Pain Global Clinical Trials Review, H2, 2015

    Low Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Low Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Low Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Low Back Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3108CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3108CTIDB
  • View Report: Research and Experts Market Report: Cognitive Disorders Global Clinical Trials Review, H2, 2015

    Cognitive Disorders Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cognitive Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Cognitive Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3107CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3107CTIDB
  • View Report: Research and Experts Market Report: Chronic Pain Global Clinical Trials Review, H2, 2015

    Chronic Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Pain Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3106CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3106CTIDB
  • View Report: Research and Experts Market Report: Chronic Back Pain Global Clinical Trials Review, H2, 2015

    Chronic Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Chronic Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Chronic Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3105CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3105CTIDB
  • View Report: Research and Experts Market Report: Psychotic Major Depression Global Clinical Trials Review, H2, 2015

    Psychotic Major Depression Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Psychotic Major Depression Global Clinical Trials Review, H2, 2015" provides an overview of Psychotic Major Depression clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3104CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3104CTIDB
  • View Report: Research and Experts Market Report: Memory Impairment Global Clinical Trials Review, H2, 2015

    Memory Impairment Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Memory Impairment Global Clinical Trials Review, H2, 2015" provides an overview of Memory Impairment clinical trials scenario. This report provides top line data relating to the clinical trials on Memory...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3103CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3103CTIDB
  • View Report: Research and Experts Market Report: Essential Tremor Global Clinical Trials Review, H2, 2015

    Essential Tremor Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Essential Tremor Global Clinical Trials Review, H2, 2015" provides an overview of Essential Tremor clinical trials scenario. This report provides top line data relating to the clinical trials on Essential...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3102CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3102CTIDB
  • View Report: Research and Experts Market Report: Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015

    Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H2, 2015" provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) clinical trials scenario....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3101CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3101CTIDB
  • View Report: Research and Experts Market Report: Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015

    Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2015" provides an overview of Cerebral Infarction (Brain Infarction) clinical trials scenario. This report provides top line...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3100CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3100CTIDB
  • View Report: Research and Experts Market Report: Brain Edema Global Clinical Trials Review, H2, 2015

    Brain Edema Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Brain Edema Global Clinical Trials Review, H2, 2015" provides an overview of Brain Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Brain Edema. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3099CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3099CTIDB
  • View Report: Research and Experts Market Report: Binge Eating Disorder Global Clinical Trials Review, H2, 2015

    Binge Eating Disorder Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Binge Eating Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Binge Eating Disorder clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3098CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3098CTIDB
  • View Report: Research and Experts Market Report: Acute Stress Disorder Global Clinical Trials Review, H2, 2015

    Acute Stress Disorder Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Acute Stress Disorder Global Clinical Trials Review, H2, 2015" provides an overview of Acute Stress Disorder clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3097CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3097CTIDB
  • View Report: Research and Experts Market Report: Childhood Epilepsy Global Clinical Trials Review, H2, 2015

    Childhood Epilepsy Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Childhood Epilepsy Global Clinical Trials Review, H2, 2015" provides an overview of Childhood Epilepsy clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3096CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3096CTIDB
  • View Report: Research and Experts Market Report: Bladder Pain Global Clinical Trials Review, H2, 2015

    Bladder Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Bladder Pain Global Clinical Trials Review, H2, 2015" provides an overview of Bladder Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Pain....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3095CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3095CTIDB
  • View Report: Research and Experts Market Report: Back Pain Global Clinical Trials Review, H2, 2015

    Back Pain Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Back Pain Global Clinical Trials Review, H2, 2015" provides an overview of Back Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Back Pain. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3094CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3094CTIDB
  • View Report: Research and Experts Market Report: Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015

    Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Appetite (Eating) Disorders Global Clinical Trials Review, H2, 2015" provides an overview of Appetite (Eating) Disorders clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3093CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3093CTIDB
  • View Report: Research and Experts Market Report: Complex Partial Seizure Global Clinical Trials Review, H2, 2015

    Complex Partial Seizure Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Complex Partial Seizure Global Clinical Trials Review, H2, 2015" provides an overview of Complex Partial Seizure clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3092CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3092CTIDB
  • View Report: Research and Experts Market Report: Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015

    Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Attention Deficit Hyperactivity Disorder (ADHD) Global Clinical Trials Review, H2, 2015" provides an overview of Attention Deficit Hyperactivity Disorder (ADHD) clinical trials scenario. This report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3091CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3091CTIDB
  • View Report: Research and Experts Market Report: Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015

    Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Alcohol Withdrawal Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Alcohol Withdrawal Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3090CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3090CTIDB
  • View Report: Research and Experts Market Report: Cholelithiasis Global Clinical Trials Review, H2, 2015

    Cholelithiasis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, H2, 2015" provides an overview of Cholelithiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholelithiasis....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3089CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3089CTIDB
  • View Report: Research and Experts Market Report: Colonic Diverticulitis Global Clinical Trials Review, H2, 2015

    Colonic Diverticulitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Colonic Diverticulitis Global Clinical Trials Review, H2, 2015" provides an overview of Colonic Diverticulitis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3088CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3088CTIDB
  • View Report: Research and Experts Market Report: Proctitis Global Clinical Trials Review, H2, 2015

    Proctitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Proctitis Global Clinical Trials Review, H2, 2015" provides an overview of Proctitis clinical trials scenario. This report provides top line data relating to the clinical trials on Proctitis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3087CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3087CTIDB
  • View Report: Research and Experts Market Report: Fecal Incontinence Global Clinical Trials Review, H2, 2015

    Fecal Incontinence Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Fecal Incontinence Global Clinical Trials Review, H2, 2015" provides an overview of Fecal Incontinence clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3086CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3086CTIDB
  • View Report: Research and Experts Market Report: Dyspepsia Global Clinical Trials Review, H2, 2015

    Dyspepsia Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2015" provides an overview of Dyspepsia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyspepsia. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3085CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3085CTIDB
  • View Report: Research and Experts Market Report: Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015

    Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Irritable Bowel Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Irritable Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3084CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3084CTIDB
  • View Report: Research and Experts Market Report: Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015

    Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Alcoholic Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3083CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3083CTIDB
  • View Report: Research and Experts Market Report: Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015

    Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H2, 2015" provides an overview of Non Alcoholic Fatty Liver Disease (NAFLD) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3082CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3082CTIDB
  • View Report: Research and Experts Market Report: Traveler

    Traveler's Diarrhea Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Traveler's Diarrhea Global Clinical Trials Review, H2, 2015" provides an overview of Traveler's Diarrhea clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3081CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3081CTIDB
  • View Report: Research and Experts Market Report: Systemic Mastocytosis Global Clinical Trials Review, H2, 2015

    Systemic Mastocytosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Systemic Mastocytosis Global Clinical Trials Review, H2, 2015" provides an overview of Systemic Mastocytosis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3080CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3080CTIDB
  • View Report: Research and Experts Market Report: Steatohepatitis Global Clinical Trials Review, H2, 2015

    Steatohepatitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Steatohepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Steatohepatitis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3079CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3079CTIDB
  • View Report: Research and Experts Market Report: Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015

    Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Primary Biliary Cirrhosis Global Clinical Trials Review, H2, 2015" provides an overview of Primary Biliary Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3078CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3078CTIDB
  • View Report: Research and Experts Market Report: Pouchitis Global Clinical Trials Review, H2, 2015

    Pouchitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Pouchitis Global Clinical Trials Review, H2, 2015" provides an overview of Pouchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Pouchitis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3077CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3077CTIDB
  • View Report: Research and Experts Market Report: Nausea Global Clinical Trials Review, H2, 2015

    Nausea Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Nausea Global Clinical Trials Review, H2, 2015" provides an overview of Nausea clinical trials scenario. This report provides top line data relating to the clinical trials on Nausea. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3076CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3076CTIDB
  • View Report: Research and Experts Market Report: Liver Diseases Global Clinical Trials Review, H2, 2015

    Liver Diseases Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Liver Diseases Global Clinical Trials Review, H2, 2015" provides an overview of Liver Diseases clinical trials scenario. This report provides top line data relating to the clinical trials on Liver Diseases....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3075CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3075CTIDB
  • View Report: Research and Experts Market Report: Gastroparesis Global Clinical Trials Review, H2, 2015

    Gastroparesis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Gastroparesis Global Clinical Trials Review, H2, 2015" provides an overview of Gastroparesis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroparesis....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3074CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3074CTIDB
  • View Report: Research and Experts Market Report: Jaundice Global Clinical Trials Review, H2, 2015

    Jaundice Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Jaundice Global Clinical Trials Review, H2, 2015" provides an overview of Jaundice clinical trials scenario. This report provides top line data relating to the clinical trials on Jaundice. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3073CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3073CTIDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Crohn's Disease (Regional Enteritis) Global Clinical Trials Review, H2, 2015" provides an overview of Crohn's Disease (Regional Enteritis) clinical trials scenario. This report provides top...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3072CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3072CTIDB
  • View Report: Research and Experts Market Report: Cirrhosis Global Clinical Trials Review, H2, 2015

    Cirrhosis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Cirrhosis Global Clinical Trials Review, H2, 2015" provides an overview of Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Cirrhosis. Report...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3071CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3071CTIDB
  • View Report: Research and Experts Market Report: Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015

    Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Atypical Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) Global Clinical Trials Review, H2, 2015" provides an overview of Atypical Hemolytic Uremic Syndrome (Nondiarrhea-...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3070CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3070CTIDB
  • View Report: Research and Experts Market Report: Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015

    Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015" provides an overview of Nonerosive Reflux Disease (NERD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3069CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3069CTIDB
  • View Report: Research and Experts Market Report: Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015

    Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Spontaneous Bacterial Peritonitis Global Clinical Trials Review, H2, 2015" provides an overview of Spontaneous Bacterial Peritonitis clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3068CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3068CTIDB
  • View Report: Research and Experts Market Report: Short Bowel Syndrome Global Clinical Trials Review, H2, 2015

    Short Bowel Syndrome Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Short Bowel Syndrome Global Clinical Trials Review, H2, 2015" provides an overview of Short Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3067CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3067CTIDB
  • View Report: Research and Experts Market Report: Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015

    Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Primary Sclerosing Cholangitis Global Clinical Trials Review, H2, 2015" provides an overview of Primary Sclerosing Cholangitis clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3066CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3066CTIDB
  • View Report: Research and Experts Market Report: Postoperative Ileus Global Clinical Trials Review, H2, 2015

    Postoperative Ileus Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Postoperative Ileus Global Clinical Trials Review, H2, 2015" provides an overview of Postoperative Ileus clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3065CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3065CTIDB
  • View Report: Research and Experts Market Report: Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015

    Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015


    2015-12-16
    GlobalData's clinical trial report, “Post Operative Nausea And Vomiting Global Clinical Trials Review, H2, 2015" provides an overview of Post Operative Nausea And Vomiting clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3064CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3064CTIDB
  • View Report: Research and Experts Company Report: Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review

    Otsuka Holdings Co., Ltd. (4578) - Financial and Strategic SWOT Analysis Review


    2016-03-22
    Otsuka Holdings Co., Ltd. (Otsuka) is a holding company, which operates various businesses such as pharmaceuticals, nutraceuticals, consumer products and other businesses through its subsidiaries. It focuses on the research and development, manufacture,...
  • Company Report
  • Life Sciences
  • Japan
  • $300.00
  • Report 05IC-GDPH219028FSA has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDPH219028FSA
  • View Report: Research and Experts Company Report: Kowa Company, Ltd. - Strategic SWOT Analysis Review

    Kowa Company, Ltd. - Strategic SWOT Analysis Review


    2016-08-09
    Kowa Company, Ltd. (Kowa) is a global enterprise that develops and manufactures various products. It carries out the manufacturing of over the counter (OTC) products, ethical drugs and medical equipment; import and export of LED lighting equipment, optica...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH30783SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH30783SA
  • View Report: Research and Experts Company Report: Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review

    Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review


    2016-09-07
    Daiichi Sankyo Company, Limited (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs,...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH5751FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH5751FSA
  • View Report: Research and Experts Company Report: Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review

    Shionogi & Co., Ltd. (4507) - Financial and Strategic SWOT Analysis Review


    2016-09-20
    Shionogi & Co., Ltd., (Shionogi) is a pharmaceutical company that focuses on the research, development, manufacturing, and marketing of pharmaceutical products and other related products for the treatment of disorders in the areas of metabolism, infec...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH2619FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH2619FSA
  • View Report: Research and Experts Company Report: Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review

    Nippon Kayaku Co., Ltd. (4272) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Nippon Kayaku Co., Ltd. (Nippon Kayaku) is a chemical company, which undertakes the development, manufacturing and sale of functional chemicals, pharmaceuticals and safety systems. The company's product portfolio includes epoxy resins, UV-curing...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH31776FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH31776FSA
  • View Report: Research and Experts Company Report: Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review

    Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review


    2016-06-01
    Vical Incorporated (Vical) is a biopharmaceutical company, which focuses on research and development on DNA delivery technologies for the prevention and treatment of life-threatening diseases and vaccines for infectious diseases and cardiovascular therapi...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH1730FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH1730FSA
  • View Report: Research and Experts Company Report: Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

    Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    Astellas Pharma Inc. (Astellas) is one of the leading global pharmaceutical companies, which focuses on the research, development, manufacture and commercialization of a wide range of pharmaceuticals. The company’s product portfolio comprises both...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH27458FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH27458FSA
  • View Report: Research and Experts Company Report: BioCryst Pharmaceuticals, Inc. (BCRX) - Financial and Strategic SWOT Analysis Review

    BioCryst Pharmaceuticals, Inc. (BCRX) - Financial and Strategic SWOT Analysis Review


    2016-05-24
    BioCryst Pharmaceuticals, Inc. (BioCryst) is a biotechnology company which designs, optimizes and develops small molecule drugs that block key enzymes in the pathogenesis of diseases. The company focuses on infectious diseases and hereditary Angioedema....
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH66540FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH66540FSA
  • View Report: Research and Experts Company Report: Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review

    Chugai Pharmaceutical Co., Ltd. (4519) - Financial and Strategic SWOT Analysis Review


    2016-06-21
    Chugai Pharmaceutical Co., Ltd. (Chugai) is a subsidiary of Hoffmann-La Roche Ltd which focus on the manufacturing marketing, import and export of new pharmaceutical products. The company's product portfolio focuses on various therapeutic areas inclu...
  • Company Report
  • Life Sciences
  • Japan
  • $125.00
  • Report 05IC-GDPH28303FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH28303FSA
  • View Report: Research and Experts Market Report: Plexiform Neurofibroma Global Clinical Trials Review, H2, 2015

    Plexiform Neurofibroma Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Plexiform Neurofibroma Global Clinical Trials Review, H2, 2015" provides an overview of Plexiform Neurofibroma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2990CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC2990CTIDB
  • View Report: Research and Experts Market Report: Adenomas Global Clinical Trials Review, H2, 2015

    Adenomas Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Adenomas Global Clinical Trials Review, H2, 2015" provides an overview of Adenomas clinical trials scenario. This report provides top line data relating to the clinical trials on Adenomas. Report includes...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2989CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC2989CTIDB
  • View Report: Research and Experts Market Report: Aspiration Pneumonitis Global Clinical Trials Review, H2, 2015

    Aspiration Pneumonitis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Aspiration Pneumonitis Global Clinical Trials Review, H2, 2015" provides an overview of Aspiration Pneumonitis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2978CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC2978CTIDB
  • View Report: Research and Experts Market Report: Tenosynovitis Global Clinical Trials Review, H2, 2015

    Tenosynovitis Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Tenosynovitis Global Clinical Trials Review, H2, 2015" provides an overview of Tenosynovitis clinical trials scenario. This report provides top line data relating to the clinical trials on Tenosynovitis....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2958CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC2958CTIDB
  • View Report: Research and Experts Market Report: Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015

    Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015


    2015-11-30
    GlobalData's clinical trial report, “Spinocerebellar Ataxias Global Clinical Trials Review, H2, 2015" provides an overview of Spinocerebellar Ataxias clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC3011CTIDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC3011CTIDB
  • View Report: Research and Experts Industry Report: Pharmaceutical Industry Business Confidence Report H1 2015

    Pharmaceutical Industry Business Confidence Report H1 2015


    2015-02-28
    “Pharmaceutical Industry Business Confidence Report H1 2015” is a new report by Kable that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within...
  • Industry Report
  • Pharmaceuticals
  • Global
  • $1,950.00
  • Report 01GH-KG4410PR has a star rating of 3.5 out of 5
  • Go to More information on Report 01GH-KG4410PR
  • View Report: Research and Experts Company Report: Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report

    Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report


    2013-01-30
    ICD Research's "Daiichi Sankyo Company, Ltd : Pharmaceuticals and Healthcare - Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overvie...
  • Company Report
  • Pharmaceuticals
  • Japan
  • $125.00
  • Report 01H3-SW2108CP has a star rating of 2.5 out of 5
  • Go to More information on Report 01H3-SW2108CP
  • Industries and Sectors

    • Pharmaceuticals (212)
    • Musculoskeletal... (2)
    • Nutritional Disorders... (1)
    • Oncology (34)
    • Infectious Disease... (15)
    • Hematological Disorders... (1)
    • Immunology (2)
    • Central Nervous... (13)
    • Cardiovascular (15)
    • Healthcare (43)
    • Metabolic Disorders... (6)
    • Automotive (1)
    • Respiratory (3)
    • Life Sciences (79)
    • Gastrointestinal... (1)
    • Genetic Disorders... (1)
    • Unassigned (2)
    • Iron and steel Construction... (17)
    • Medical Devices (2)

    Geographic Regions

    • Global (436)
    • Japan (11)
    • Australia (1)
    • United States (2)

    Report Types

    • Market Report (435)
    • Company Report (13)
    • Industry Report (2)

    Return to Company List

    Page created and rendered - Cache updated [3.83711s]